Director/PDMR Shareholding

RNS Number : 0058Z

Smith & Nephew Plc

19 January 2022

 

SMITH & NEPHEW PLC

19 January 2022

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 18 January 2022, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
Identification code	ISIN: US83175M2052
Nature of the transaction	Purchase of American Depository Shares as participants of the Company's Employee Stock Purchase Plan
Date of Transaction	2022 - 01 - 13
Place of Transaction	New York Stock Exchange

Name (Position)	Director / PDMR	Price ($)	Volume	Aggregated information	Total Ordinary Share Holding following the transaction *	Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
Bradley Cannon (President Sports Medicine & ENT)	PDMR	29.43	284.93272	N/A Single Transaction	78,530.17832 (including 2,718.50860 in ADS')	0.00887%
Alison Parkes (Chief Compliance Officer)	PDMR	29.43	220.86307	N/A Single Transaction	1,538.24834 (including 400.24362 in ADS')	0.00017%

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Susan Swabey  

Company Secretary

Smith & Nephew plc

Tel: [phone]

 

END

 

 

DSHFLFSRLAIALIF